Somatic DNA oxidative damage and coronary disease.
Luft
Friedrich C
FC
Franz Volhard Clinic, HELIOS Kliniken Berlin, Medical Faculty of the Charité, Humboldt University, Wiltbergstrasse 50, 13125 Berlin-Buch, Germany. luft@fvk-berlin.de
D015906:Angioplasty, Balloon, Coronary / Q000009:adverse effects; D003327:Coronary Disease / Q000235:genetics* / Q000378:metabolism* / Q000628:therapy; D004249:DNA Damage; D048909:Diabetes Complications / Q000235:genetics; D005982:Glutathione Transferase / Q000235:genetics / Q000378:metabolism; D006147:Guanine / Q000031:analogs & derivatives* / Q000378:metabolism; D006801:Humans; D008297:Male; D015162:Micronucleus Tests; D018384:Oxidative Stress; D000071137:Poly (ADP-Ribose) Polymerase-1; D011065:Poly(ADP-ribose) Polymerases / Q000378:metabolism
D005982:Glutathione Transferase; D006147:Guanine; D000071137:Poly (ADP-Ribose) Polymerase-1; D011065:Poly(ADP-ribose) Polymerases; C024829:8-hydroxyguanine; C499320:PARP1 protein, human; C413545:glutathione S-transferase T1
FASEB J. 1998 Oct;12 (13):1397-400
9761783
J Am Coll Cardiol. 2002 Sep 4;40(5):862-8
12225708
FASEB J. 2003 Jul;17(10):1195-214
12832285
Circulation. 2002 Aug 20;106(8):927-32
12186795
FASEB J. 2005 Mar;19(3):485-7
15601670
Oncogene. 2005 Feb 17;24(8):1328-37
15608683
FASEB J. 2001 Mar;15(3):752-7
11259393
Int J Mol Med. 2002 Jun;9(6):659-64
12011985
Pharmacol Rev. 2002 Sep;54(3):375-429
12223530
J Mol Med (Berl). 2005 Apr;83(4):279-86
15770499